Question 1

What specific tests will I undergo during this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Montrachet Cohort) clinical trial (NCT01766596). Contact the study team or your healthcare provider for specific answers.

Question 2

How might the results of this study affect my treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Montrachet Cohort) clinical trial (NCT01766596). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any risks associated with the Optical Coherence Tomography procedure?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Montrachet Cohort) clinical trial (NCT01766596). Contact the study team or your healthcare provider for specific answers.

Question 4

What should I expect during the consultations and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Montrachet Cohort) clinical trial (NCT01766596). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my participation contribute to understanding eye and brain health?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Montrachet Cohort) clinical trial (NCT01766596). Contact the study team or your healthcare provider for specific answers.

What this study is about